期刊文献+

血浆B型钠尿肽前体浓度的动态变化对脓毒性休克患者心肌抑制严重程度及预后的评估意义 被引量:7

Clinical significance of dynamic monitoring of plasma Pro-B-type Natriuretic Peptide in the evaluation of prognostic value and myocardial dysfunction in patients with septic shock
原文传递
导出
摘要 目的探讨动态监测脓毒性休克患者的血浆B型脑钠肽前体(Pro—BNP)浓度对脓毒性休克心功能抑制程度和患者预后的评估作用。方法测定102例脓毒性休克患者第1、3、5天血浆Pro-BNP浓度,根据28d存活情况分为存活组和死亡组,按血流动力学指标分为心功能减低组(CI〈3.0)和心功能正常组(CI≥3.0),分析其在各组之间的差异,并统计ICU病死率及28d病死率,分析Pro—BNP浓度对临床结局的预测价值。结果28d存活组人院第1、3、5天的血浆Pro-BNP浓度呈明显下降趋势[(1649.0±257.5)、(1867.6±291.7)、(1229.9±194.5)ng/L],而死亡组患者血浆Pro—BNP浓度则呈上升趋势[(4128.8±1051.1)、(5315.9±925.4)、(6899.9±1327.9)ng/L],两组第1、3、5天的血浆Pro—BNP浓度比较差异均有统计学意义(t值分别为3.057、5.083、6.290,P均〈0.01);心功能正常组患者28d病死率和人院第1、3、5天的Pro—BNP浓度明显低于心功能减低组[28d病死率:62.1%与20.0%;(1592.8±362.2)与(4556.6±732.7)ng/L,(2933.6±421.7)与(5768.5±793.7)ng/L,(3014.5±587.5)与(8873.9±1670.1)ng/L](x2=20.635,P=0.000,t值分别为.3.626、3.154、3.310,P均〈0.01)。以入院第5天的Pro—BNP浓度〉3053ng/L作为预测28d病死率的临界点,其敏感度为88.4%,特异度为91.5%;以入院第5天的Pro-BNP浓度〉2378ng/L作为预测住院病死率的临界点,其敏感度为84.9%,特异度为91.8%。多因素分析显示对于28d病死率APACHEII评分及第5天的Pro—BNP浓度是独立预测因素,第5天的Pro—BNP浓度是预测住院病死率的独立预测因素。结论动态监测血浆Pro-BNP浓度可以评价脓毒性休克患者的心脏抑制程度,入院第5天Pro—BNP浓度可以预测脓毒性休克患者的预后。 Objective To assess the effects of dynamic monitoring of plasma Pro-B-type Natriuretic Peptide(Pro-BNP) in the evaluation of prognostic value and myocardial dysfunction in patients with septic shock. Methods The levels of plasma Pro-BNP were tested in 102 patients with septic shock on the 1,3, and 5 days. Data on ICU mortality and 28-day mortality were collected. The patients were divided into non-dysfunction group ( CI 〈3.0) and cardiac dysfunction group (CI≥3.0) according to levels of hemodynamic variables ( CI level). The prognostic value of plasma Pro-BNP was analyzed. Results Plasma Pro-BNP levels on the 1,3 and 5 days in 28-day survivors have a significant declining trend [ ( 1649. 0±257.5 ) ng/L, ( 1867.6 ± 291.7 ) ng/L vs. (1229. 9± 194. 5 ) ng/L ), while plasma Pro-BNP levels in non-survivors have an increasing trend [ (4128.8±1051.1 ), ( 5315.9 ±925.4 ) vs. ( 6899. 9± 1327.9 ) ng/L ]. There is statistical significance of plasma Pro-BNP levels at day 1,3 and 5 for the two groups ( t = 3.057,5.083, and 6. 290 respectively, P 〈 0. 01 ). The 28-day mortality and Plasma Pro-BNP levels in cardiac dysfunction group were higher than of non- dysfunction group ( 28-day mortality : 62. 1% vs. 20. 0% ; Pro-BNP1 : ( 1592. 8 ±362. 2 )ng/L vs. (4556. 6 ± 732. 7) ng/L; Pro-BNP3 : ( 2933.6 ± 421.7 ) vs. (5768.5 ± 793.7 ) ng/L, Pro-BNP5 : ( 3014. 5 ± 587. 5 ) ng/L vs. (8873.9 ± 1670. 1 ) ng/L (X2 = 20. 635, P = 0. 000, t = 3. 626,3. 154,3. 310, P 〈 0. O1 ]. Pro-BNP level greater than 3053 ng/L on the 5-day was an independent prognostic indicator of 28-day mortality ( sensitivity : 88.4% ;specificity :91.5% ). Pro-BNP level greater than 2378 ng/L on the 5-day was an independent prognostic indicator of hospital mortality ( sensitivity: 84. 9% ; specificity: 91.8% ) . In multivariate logistic regression analyses,Pro-BNP level and APACHE score were independent predictors of 28-day mortality and hospital mortality. Conclusion Plasma Pro-BNP level shows obvious significance in evaluation of sepsis-induced myocardial depression severity in patients with septic shock. Pro-BNP level in ICU at day 5 after inclusion is an independent prognostic marker of mortality in septic shock.
出处 《中国综合临床》 2012年第12期1268-1272,共5页 Clinical Medicine of China
基金 北京市教育委员会科技发展基金(kin200710025027)
关键词 脓毒性休克 B型钠尿肽前体 预后 Septic shock Pro-B-type natriuretic peptide Prognosis
  • 相关文献

参考文献19

二级参考文献58

  • 1Richard S, Hotchkiss RS, Karl IE, et al. The pathophysiology and treatment of sepsis[J]. N Eng J Med, 2003, 348(2):138-150.
  • 2Stuber F. Effects of genomic polymorphisms on the cause of sepsis: Is there a concept for gene therapy[J]. J Am Soc Nephrol, 2001, 12 (Suppl 17): S60-64.
  • 3Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock[J]. N Engl J Med, 2001, 345(19) : 1368-1377.
  • 4Levy/VIM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conferencep[J]. Crit Care Med, 2003, 31(4) : 1250-1256.
  • 5Dellinger RP, Levy MM, Cadet JM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008[J]. Intensive Care Med, 2008, 34(1): 17-60.
  • 6Adams JE 3rd, Bordor GS, Davita-Rornan VG, et al. Cardiac troponin Ⅰ: a marker with high specificity for cardiac injury[J]. Circulation, 1993, 88(1):101-106.
  • 7Ammarm P, Maggiorini M, Bertel O, et al. Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes[J]. J Am Coll Cardiol, 2003, 41(11):2004-2009.
  • 8Povoa P, Almeida E, Moreira P, etal. C-reactive protein as an indicator of sepsis[J]. Intensive Care Med, 1998, 24(10):1052-1056.
  • 9Black S, Kushner I, Samols D. C-reactive protein[J]. J Biol Chem, 2004, 279(47) : 48487-48490.
  • 10de Denus S,Pharand C,Williamson D,et al.Brain natri-uretic peptide in the management of heart failure:the versatile neurohormone[J].Chest,2004,125(2):652-668.

共引文献52

同被引文献81

  • 1乔万海,李小珍,裴红红.危重病患者细胞因子和氧代谢指标的动态变化[J].中国危重病急救医学,2004,16(8):493-493. 被引量:19
  • 2许强,吴海云,王士雯.血浆心钠素及脑钠素检测对预测老年重度脓毒症并发心功能异常及预后的价值[J].中国综合临床,2005,21(5):385-387. 被引量:16
  • 3李文华,宋志芳,单慧敏.乌司他丁对脓毒症大鼠肺损伤的保护作用[J].中华急诊医学杂志,2007,16(2):132-137. 被引量:23
  • 4王国兴,沈潞华,谢苗荣,金明,龙维.脓毒症时大鼠心脏的变化及血管紧张素转化酶抑制剂的保护作用[J].中华急诊医学杂志,2007,16(2):138-142. 被引量:12
  • 5Mak GS, DeMaria A, Clopton P,et al. Utility of B-natriureticpeptide in the evaluation of left ventricular diastolic function :comparison with tissue Doppler imaging recordings [ J]. Am HeartJ,2004,148(5) :895-902.
  • 6Nagueh SF, Middleton KJ, Kopelen HA, et al. Doppler tissueimaging;a noninvasive technique for evaluation of left ventricularrelaxation and estimation of filling pressures [J]. J Am CollCardiol,1997,30(6) : 1527-1533.
  • 7Ommen SR,Nishimura RA, Appleton CP, et al. Clinical utility ofDoppler echocardiography and tissue Doppler imaging in theestimation of left ventricular filling pressures : A comparativesimultaneous Doppler-catheterization study [ J]. Circulation,2000,102(15):1788-1794.
  • 8Schiller NB,Shah PM,Crawford M,et al. Recommendations forquantitation of the left ventricle by two-dimensional echocardiog-raphy. American Society of Echocardiography Committee onStandards, Subcommittee on Quantitation of Two-DimensionalEchocardiograms [J]. J Am Soc Echocardiogr, 1989,2(5) :358-367.
  • 9Feigenbaum H,Armstrong WF,Ryan T.王志斌,译.菲根鲍姆超声心动图学[M].6版.北京:人民卫生出版社,2009:159-162.
  • 10Quinones MA, Otto CM, Stoddard M, et al. Recommendations forquantification of Doppler echocardiography : a report from theDoppler Quantification Task Force of the Nomenclature andStandards Committee of the American Society of Echocardiography[J]. J Am Soc Echocardiogr,2002,15(2) : 167-184.

引证文献7

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部